A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study

Pol Arch Intern Med. 2018 Dec 21;128(12):791-795. doi: 10.20452/pamw.4387. Epub 2018 Dec 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Carcinoma, Neuroendocrine / diagnosis*
  • Carcinoma, Neuroendocrine / metabolism
  • Carcinoma, Neuroendocrine / therapy*
  • Clinical Protocols*
  • Female
  • Humans
  • Male
  • Multicenter Studies as Topic
  • Neoplasm Metastasis
  • Randomized Controlled Trials as Topic
  • Receptor, Cholecystokinin B / metabolism*
  • Thyroid Neoplasms / diagnosis*
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / therapy*

Substances

  • Receptor, Cholecystokinin B

Supplementary concepts

  • Thyroid cancer, medullary